DrugPatentWatch Database Preview
Litigation Details for In re: Palbociclib Patent Litigation (D. Del. 2019)
» See Plans and Pricing
In re: Palbociclib Patent Litigation (D. Del. 2019)
| Docket | Start Trial | Date Filed | 2019-10-02 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | None | Referred To | |
| Patents | 6,936,612; 7,456,168 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in In re: Palbociclib Patent Litigation
The small molecule drug covered by the patents cited in this case is Start Trial .
Details for In re: Palbociclib Patent Litigation (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-07-24 | 151 | Notice of Service | Invalidity Contentions Regarding U.S. Patent Nos. RE47,739, 6,936,612, and 7,456,168 filed by Alembic Pharmacauticals…Palbociclib Patent Litigation 2 October 2019 1:19-md-02912 835 Patent - Abbreviated | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
